| Due Diligence for Asset Managers |
|---|
|
You have viewed 8 of the 10 daily limit Subscribe for $29/month to gain full access |
|
⚲
|
| Keyboard |
| Camp4 Therapeutics Corp | |
|---|---|
| Ticker | CAMP |
| CIK # | 0001736730 |
| CUSIP | 13463J101 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | One Kendall Square Building 1400 West, 3Rd Floor, Cambridge, MA 02139 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Camp4 Therapeutics Corp | 2022-06-21 | 100.5 M | Exemption: 506(b) · Remaining: Indefinite · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001736730] | 10-K | |
| [0001736730] | 10-Q | |
| [0001736730] | 3 | |
| [0001736730] | 4 | |
| [0001736730] | 8-K | |
| [0001736730] | D | |
| [0001736730] | SC 13D | |
| [0001736730] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Tardiff Daniel
Stock Option (Right to Buy) · derivative
|
2025-12-11 | Grant | 145,500 | $0.00 | |
|
Maricich Yuri
Stock Option (Right to Buy) · derivative
|
2025-12-11 | Grant | 190,000 | $0.00 | |
|
Gold Kelly
Stock Option (Right to Buy) · derivative
|
2025-12-11 | Grant | 190,000 | $0.00 | |
|
Mandel-Brehm Josh
Stock Option (Right to Buy) · derivative
|
2025-12-11 | Grant | 425,000 | $0.00 | |
|
Common Stock
|
2025-09-11 | Grant | 2,941,176 | $1.53 | 4,499,999 |
|
Common Stock
|
2025-09-11 | Buy | 2,941,176 | $1.53 | 4,499,999 |
|
Common Stock
|
2025-09-11 | Buy | 85,468 | $1.53 | 130,766 |
|
Common Stock
|
2025-09-11 | Buy | 1,221,721 | $1.53 | 1,869,233 |
|
Common Stock
|
2025-09-11 | Buy | 1,221,721 | $1.53 | 1,869,233 |
|
Common Stock
|
2025-09-11 | Buy | 85,468 | $1.53 | 130,766 |
|
Common Stock
|
2025-09-11 | Buy | 6,060 | $1.65 | 9,999 |
|
Common Stock
|
2025-09-11 | Buy | 6,060 | $1.65 | 9,999 |
|
Common Stock
|
2025-09-11 | Buy | 6,060 | $1.65 | 9,999 |
|
Common Stock
|
2025-09-11 | Buy | 15,151 | $1.65 | 24,999 |
|
Boylan James P
Stock Option (Right to Buy) · derivative
|
2025-06-25 | Grant | 9,000 | $0.00 | |
|
Young Richard A
Stock Option (Right to Buy) · derivative
|
2025-06-25 | Grant | 9,000 | $0.00 | |
|
Higgins Michael J
Stock Option (Right to Buy) · derivative
|
2025-06-25 | Grant | 9,000 | $0.00 | |
|
Schwab Andrew J
Stock Option (Right to Buy) · derivative
|
2025-06-25 | Grant | 9,000 | $0.00 | |
|
Holtzman Steven H
Stock Option (Right to Buy) · derivative
|
2025-06-25 | Grant | 9,000 | $0.00 | |
|
Nashat Amir
Stock Option (Right to Buy) · derivative
|
2025-06-25 | Grant | 9,000 | $0.00 | |
| showing 20 of 87 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 48 | 39,797,262 |
| 2025-12-31 | 41 | 38,247,397 |
| 2025-09-30 | 30 | 28,210,089 |
| 2025-06-30 | 31 | 11,745,574 |
| 2025-03-31 | 41 | 12,677,519 |
| 2024-12-31 | 38 | 12,854,104 |
| 2024-09-30 | 1 | 1 |
| 2024-06-30 | 2 | 3 |
| 2024-03-31 | 2 | 3 |
| 2023-12-31 | 51 | 13,561,714 |
| 2023-09-30 | 62 | 18,665,015 |
| 2023-06-30 | 71 | 23,626,608 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Y-Intercept Hong Kong Ltd | [2026-06-30] | SOLE | 30,942 | 30,942 |
| Physician Wealth Advisors Inc | [2026-06-30] | SOLE | 0 | 242 | Prev | Page 1 | Next |